Mounjaro for men: the full UK picture

Not losing weight on Mounjaro: what should I check?

One unchanged reading cannot tell you whether Mounjaro is working. Response varies. Review the pattern, treatment history and side effects with your prescribing service. Do not change your dose, take an extra injection or severely restrict food to force the scale to move.

Deal with warning signs before the progress checklist

Severe, persistent abdominal pain, with or without nausea or vomiting: stop using Mounjaro and seek urgent medical help, as the UK patient leaflet instructs. Pain may spread to the back. Do not wait for a routine review or a reply from SHIFT.

Repeated vomiting or difficulty keeping fluids down: seek urgent advice. If there is trouble breathing, sudden swelling of the mouth or throat, or collapse, call 999. A checklist about weight should never delay care.

A useful review checklist

1. Compare comparable readings. Follow NHS England’s weighing guidance: use the same scales, a firm level floor and a similar time and clothing. Note dates rather than comparing today's reading with a vague memory. Record constipation and other symptoms too, so the prescribing service has context.
2. Write down the treatment history. Record when you started, your prescribed dose, dates of changes and any missed injections. Starting or increasing treatment is not a promise of a particular weekly loss.
3. Check practical use with the pharmacist or prescriber. Ask about your pen technique and storage if unsure. Follow the leaflet for your exact product. Do not extract leftover medicine, double a dose or devise your own schedule.
4. Look at an ordinary working day. Record meals, snacks, drinks, hunger, movement and sleep without blame. Consider whether long gaps lead to a difficult evening, or whether low appetite is preventing adequate eating. A food record is information for a conversation, not an instruction to eat less and less.
5. Record tolerability and function. Tell the service about nausea, vomiting, constipation, poor intake, weakness or difficulty with ordinary activities. Waist, appetite and health measures can provide context; they do not prove the medicine is effective or make warning signs safe to ignore.
6. Arrange the treatment review. Ask what progress they expect for your circumstances, when they will review it, and what food or activity support is available. Other conditions and medicines may need consideration. Keep those decisions with an appropriate clinician.

When does NICE recommend reviewing a poor response?

NICE's tirzepatide prescribing guide says that a loss below 5% of starting weight after six months at the highest dose the person can tolerate should lead to a discussion of response and a decision about continued treatment, considering that person's benefits and risks. It also notes that people with type 2 diabetes may lose weight more slowly.

This is a clinician-led review point, not a rule to stop by yourself after six months from the first injection. Do not wait for that point if you have side effects, difficulty eating or concerns now.

A message you can send to your prescribing service

“I started on [date]. My prescribed dose is [dose], last changed on [date]. My comparable weights are [dates and readings]. My appetite and eating have been [what is true]. I have had [symptoms or none]. Can we review my response, check how I am using the pen and agree the next step?”

Do not delay urgent care to gather those details. My Timber can support ordinary routines; it does not assess treatment response or send this message to a clinician.

For practical meals, read food during treatment. For access questions, read NHS eligibility and routes. This section is information, not a medicine sales offer.

Practical section added and its linked sources checked 6 October 2026 by the SHIFT editorial team. These are general examples, not a personal diet, exercise or treatment prescription. Independent clinical review is not claimed.